MYD88 and ovarian carcinoma: To further explore the link between TLR4 and MAD2 we next analysed the expression of MAD2, TLR4 and MyD88 in 5 additional ovarian cancer cell lines; OVCAR-3, PEO1, OAW42, KURAMOCHI and 59M cells (Fig 3A).